Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific ABCA5 EST90625 ENSG00000154265 ATP-binding cassette, sub-family A (ABC1), member 5 17 69244311-69327244 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA022032 Approved Expressed in all skin: 28.0 ABCB6 EST45597, MTABC3, umat ENSG00000115657 ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group) 2 219209768-219218990 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046723, HPA058011 Approved Validated Nucleoplasm
Golgi apparatus
Plasma membrane
Mitochondria
Cytosol Expressed in all testis: 32.5 ABCC12 MRP9 ENSG00000140798 ATP-binding cassette, sub-family C (CFTR/MRP), member 12 16 48082973-48156018 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043100 Uncertain Tissue enhanced 0 testis: 2.9 breast: 0.5 ABCC4 EST170205, MOAT-B, MOATB, MRP4 ENSG00000125257 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 13 95019829-95301446 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002476 Supported Approved Nucleoli
Plasma membrane
Cytosol Tissue enhanced 0 prostate: 68.5 epididymis: 23.3 ALG3 CDGS4, D16Ertd36e, Not56, NOT56L ENSG00000214160 ALG3, alpha-1,3- mannosyltransferase 3 184242301-184249548 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045103 Approved Expressed in all parathyroid gland: 32.7 ANKH ANK, CCAL2, CMDJ, CPPDD, HANK ENSG00000154122 ANKH inorganic pyrophosphate transport regulator 5 14704804-14871778 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA068104 Approved Cytosol Expressed in all prostate: 49.5 ANO3 C11orf25, DYT23, GENX-3947, TMEM16C ENSG00000134343 Anoctamin 3 11 26309599-26663288 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA041629 Uncertain Tissue enriched 6 epididymis: 61.3 cerebral cortex: 10.6 ANO4 FLJ34221, FLJ34272, FLJ35277, TMEM16D ENSG00000151572 Anoctamin 4 12 100717526-101128641 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA053412 Uncertain Group enriched 6 adrenal gland: 17.6;cerebral cortex: 10.0;cervix, uterine: 12.5;endometrium: 8.3;ovary: 10.9;prostate: 10.9;seminal vesicle: 11.3 testis: 2.0 ANO5 GDD1, LGMD2L, TMEM16E ENSG00000171714 Anoctamin 5 11 22193176-22283357 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA058857 Uncertain Tissue enhanced 0 parathyroid gland: 55.2 skeletal muscle: 23.6 ANO6 DKFZp313M0720, TMEM16F ENSG00000177119 Anoctamin 6 12 45215987-45440404 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038958 Approved Approved Plasma membrane
Cytosol Expressed in all adipose tissue: 90.8 ANO7 IPCA-5, NGEP, PCANAP5, PCANAP5L, TMEM16G ENSG00000146205 Anoctamin 7 2 241188509-241225377 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035730 Uncertain Tissue enhanced 0 prostate: 86.9;stomach: 26.2 small intestine: 15.7 ANO9 PIG5, TMEM16J, TP53I5 ENSG00000185101 Anoctamin 9 11 417933-442011 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA039948, HPA040112 Approved Uncertain Golgi apparatus Tissue enhanced 0 duodenum: 32.4;small intestine: 31.6 skin: 21.6 ATP13A2 CLN12, HSA9947, PARK9 ENSG00000159363 ATPase type 13A2 1 16985958-17011928 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037038, CAB037111, HPA050910, HPA054717 Approved Expressed in all cerebral cortex: 75.0 ATP13A4 DKFZp761I1011, FLJ37958 ENSG00000127249 ATPase type 13A4 3 193402077-193593111 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051932 Approved Nucleoplasm Tissue enhanced 0 epididymis: 89.1;parathyroid gland: 129.5;thyroid gland: 68.2 lung: 56.5 ATP2A2 ATP2B, DAR, SERCA2 ENSG00000174437 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 12 110280756-110351093 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA062605, HPA067892 Supported Supported Nucleoplasm Expressed in all skeletal muscle: 1006.6 ATP2B2 PMCA2 ENSG00000157087 ATPase, Ca++ transporting, plasma membrane 2 3 10324023-10708031 Enzymes, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005606 Supported Tissue enriched 7 cerebral cortex: 63.0 salivary gland: 9.2 ATP2C1 ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1 ENSG00000017260 ATPase, Ca++ transporting, type 2C, member 1 3 130850595-131016712 Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010207, HPA035116, HPA069684 Supported Validated Golgi apparatus Expressed in all prostate: 136.8 ATP7B WND ENSG00000123191 ATPase, Cu++ transporting, beta polypeptide 13 51930436-52012125 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009137, HPA013187 Supported Supported Golgi apparatus Mixed testis: 14.0 CDS1 ENSG00000163624 CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 4 84582979-84651338 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA036187 Uncertain Approved Nucleus
Nuclear membrane Mixed fallopian tube: 49.0 CDS2 ENSG00000101290 CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2 20 5126786-5197887 Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA019698 Approved Approved Endoplasmic reticulum
Cytosol Expressed in all cerebral cortex: 49.1 CLN3 BTS, JNCL ENSG00000188603 Ceroid-lipofuscinosis, neuronal 3 16 28477279-28495575 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA063280 Uncertain Expressed in all placenta: 54.9 DUOX2 LNOX2, P138(TOX), P138-TOX, THOX2 ENSG00000140279 Dual oxidase 2 15 45092650-45114344 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 gallbladder: 448.6;thyroid gland: 124.3;urinary bladder: 90.1 stomach: 38.5 ERMP1 FLJ23309, FXNA, KIAA1815 ENSG00000099219 Endoplasmic reticulum metallopeptidase 1 9 5765076-5833117 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020584 Approved Approved Nucleus
Nucleoli Tissue enhanced 0 parathyroid gland: 122.3 thyroid gland: 43.8 G6PC3 UGRP ENSG00000141349 Glucose 6 phosphatase, catalytic, 3 17 44070735-44076344 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA067052 Supported Endoplasmic reticulum Expressed in all epididymis: 82.8 GPR89A UNQ192 ENSG00000117262 G protein-coupled receptor 89A 1 145607990-145670648 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA076096 Approved Endoplasmic reticulum Mixed kidney: 20.8 GPR89B GPR89, GPR89C, SH120 ENSG00000188092 G protein-coupled receptor 89B 1 147928393-147993521 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA076096 Approved Endoplasmic reticulum Expressed in all kidney: 30.9 HM13 dJ324O17.1, H13, IMP1, IMPAS, PSENL3, PSL3, SPP, SPPL1 ENSG00000101294 Histocompatibility (minor) 13 20 31514428-31577923 Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045089, HPA056062 Approved Supported Endoplasmic reticulum Expressed in all cervix: 153.3 LBR DHCR14B, TDRD18 ENSG00000143815 Lamin B receptor 1 225401502-225428925 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049840, HPA062236 Supported Validated Nuclear membrane Expressed in all lymph node: 99.8 LMBR1 ACHP, C7orf2, FLJ11665, ZRS ENSG00000105983 Limb development membrane protein 1 7 156668946-156893230 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016592 Approved Approved Cytosol Expressed in all parathyroid gland: 45.4 LMBR1L FLJ10494, KIAA1174 ENSG00000139636 Limb development membrane protein 1-like 12 49096551-49110900 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 testis: 27.5 endometrium: 9.0 LMBRD1 bA810I22.1, C6orf209, cblF, FLJ11240 ENSG00000168216 LMBR1 domain containing 1 6 69675802-69797111 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA019547 Uncertain Expressed in all parathyroid gland: 170.0 LMBRD2 DKFZp434H2226 ENSG00000164187 LMBR1 domain containing 2 5 36098412-36151961 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA012165 Approved Approved Nucleoplasm
Cytosol Expressed in all cerebral cortex: 25.5 LMF2 TMEM112B, TMEM153 ENSG00000100258 Lipase maturation factor 2 22 50502949-50507691 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA062626 Approved Approved Centrosome Expressed in all pancreas: 38.0 LPCAT3 C3F, MBOAT5, nessy, OACT5 ENSG00000111684 Lysophosphatidylcholine acyltransferase 3 12 6976186-7018510 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Expressed in all duodenum: 126.4 MBOAT2 FLJ14415, FLJ90298, OACT2 ENSG00000143797 Membrane bound O-acyltransferase domain containing 2 2 8852690-9003813 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014836 Uncertain Approved Vesicles Tissue enhanced 0 parathyroid gland: 49.4 cerebral cortex: 29.8 MFSD4 DKFZp761N1114, FLJ25004, FLJ34577, UNQ3064 ENSG00000174514 Major facilitator superfamily domain containing 4 1 205568885-205602918 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 kidney: 75.1;stomach: 108.2 cerebral cortex: 50.8 MFSD5 MGC11308 ENSG00000182544 Major facilitator superfamily domain containing 5 12 53251251-53254405 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039773 Uncertain Expressed in all skin: 49.7 MFSD9 MGC11332 ENSG00000135953 Major facilitator superfamily domain containing 9 2 102715840-102736888 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA055293, HPA061859 Approved Approved Nucleoli Mixed duodenum: 10.1 MT-CYB COB, CYTB, MTCYB, UQCR3 ENSG00000198727 Mitochondrially encoded cytochrome b MT 14747-15887 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB032215, HPA068400 Approved Approved Mitochondria Expressed in all heart muscle: 24037.9 NIPA1 MGC35570, SPG6 ENSG00000170113 Non imprinted in Prader-Willi/Angelman syndrome 1 15 22773063-22829791 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023269 Uncertain Tissue enhanced 0 cerebral cortex: 38.3 parathyroid gland: 16.6 NIPA2 ENSG00000140157 Non imprinted in Prader-Willi/Angelman syndrome 2 15 22838641-22868384 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA067160, HPA071342 Approved Approved Golgi apparatus Expressed in all appendix: 45.7 NIPAL1 DKFZp686A06115, NPAL1 ENSG00000163293 NIPA-like domain containing 1 4 47914142-48040173 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA036765 Uncertain Approved Golgi apparatus Tissue enhanced 0 esophagus: 24.2;skin: 31.0 rectum: 14.9 NIPAL2 FLJ13955, NPAL2 ENSG00000104361 NIPA-like domain containing 2 8 98189833-98294393 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA071759 Uncertain Mixed skin: 62.5 NIPAL3 DJ462O23.2, NPAL3 ENSG00000001461 NIPA-like domain containing 3 1 24415794-24472976 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039978 Approved Approved Nucleoplasm Expressed in all prostate: 94.7 NIPAL4 ICHYN ENSG00000172548 NIPA-like domain containing 4 5 157460019-157474717 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA038259 Approved Tissue enhanced 0 skin: 42.0 esophagus: 10.2 PCNXL2 FLJ11383, KIAA0435 ENSG00000135749 Pecanex-like 2 (Drosophila) 1 232983435-233295713 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA013815, HPA014427 Uncertain Approved Endoplasmic reticulum Mixed cerebral cortex: 14.0 POMT1 LGMD2K ENSG00000130714 Protein-O-mannosyltransferase 1 9 131502902-131523806 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA065252 Approved Golgi apparatus Expressed in all testis: 62.7 PORCN DHOF, MG61, por, PORC, PPN ENSG00000102312 Porcupine homolog (Drosophila) X 48508962-48520814 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049215, HPA058413 Approved Approved Vesicles Mixed adrenal gland: 34.6 PTDSS1 KIAA0024, PSS1, PSSA ENSG00000156471 Phosphatidylserine synthase 1 8 96261715-96336995 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016852 Uncertain Approved Nucleoplasm
Endoplasmic reticulum Mixed parathyroid gland: 13.9 PTDSS2 PSS2 ENSG00000174915 Phosphatidylserine synthase 2 11 448268-491399 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038928, HPA038929 Approved Expressed in all testis: 25.4 RHCE CD240CE, RH ENSG00000188672 Rh blood group, CcEe antigens 1 25362249-25430192 Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 6 bone marrow: 28.9 epididymis: 5.1 RHD CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI ENSG00000187010 Rh blood group, D antigen 1 25272393-25330445 Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 bone marrow: 9.2 skin: 2.5 RP11-468E2.1 ENSG00000254692 14 24189157-24213473 Predicted membrane proteins Evidence at protein level Evidence at protein level HPA059249 Approved Approved Golgi apparatus Expressed in all parathyroid gland: 53.3 SCN7A NaG, Nav2.1, Nav2.2, SCN6A ENSG00000136546 Sodium channel, voltage gated, type VII alpha subunit 2 166403573-166494247 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004879 Uncertain Tissue enhanced 0 ovary: 63.0 lung: 41.0 SEC61A1 ENSG00000058262 Sec61 translocon alpha 1 subunit 3 128051641-128071683 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022076 Supported Endoplasmic reticulum Expressed in all cervix: 217.0 SEC61A2 FLJ10578 ENSG00000065665 Sec61 translocon alpha 2 subunit 10 12129637-12169961 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 51.4 testis: 32.3 SERINC5 C5orf12, TPO1 ENSG00000164300 Serine incorporator 5 5 80111651-80256079 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA037898, HPA037899 Supported Uncertain Nucleus
Golgi apparatus
Vesicles Mixed testis: 55.9 SGPP1 ENSG00000126821 Sphingosine-1-phosphate phosphatase 1 14 63684214-63728039 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053149, HPA064908 Approved Supported Nucleus Expressed in all placenta: 34.5 SGPP2 FLJ39004, SPP2 ENSG00000163082 Sphingosine-1-phosphate phosphatase 2 2 222424517-222560948 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 parathyroid gland: 58.4 thyroid gland: 33.8 SLC12A1 NKCC2 ENSG00000074803 Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 15 48191664-48304078 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014967, HPA018107 Supported Tissue enriched 456 kidney: 773.2 testis: 1.6 SLC16A4 MCT4, MCT5 ENSG00000168679 Solute carrier family 16, member 4 1 110362848-110391082 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA046986, HPA060163 Approved Approved Microtubules
Cytokinetic bridge
Cytosol Tissue enhanced 0 kidney: 124.3 placenta: 39.9 SLC17A3 NPT4 ENSG00000124564 Solute carrier family 17 (organic anion transporter), member 3 6 25833066-25882286 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016569 Uncertain Tissue enriched 9 kidney: 167.2 liver: 18.5 SLC1A3 EA6, EAAT1, GLAST ENSG00000079215 Solute carrier family 1 (glial high affinity glutamate transporter), member 3 5 36606355-36688334 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002573, HPA037467, HPA037468 Supported Approved Nucleoli
Mitochondria Tissue enriched 16 cerebral cortex: 519.6 adipose tissue: 31.7 SLC1A4 ASCT1, SATT ENSG00000115902 Solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 2 64988477-65023865 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034963, HPA034964 Approved Validated Microtubule organizing center
Centrosome Expressed in all cerebral cortex: 79.3 SLC1A5 AAAT, ASCT2, M7V1, RDRC ENSG00000105281 Solute carrier family 1 (neutral amino acid transporter), member 5 19 46774883-46788594 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035239, HPA035240 Supported Validated Plasma membrane Expressed in all epididymis: 117.4 SLC1A7 EAAT5 ENSG00000162383 Solute carrier family 1 (glutamate transporter), member 7 1 53087179-53142632 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 gallbladder: 8.5 fallopian tube: 4.4 SLC22A23 C6orf85, FLJ22174 ENSG00000137266 Solute carrier family 22, member 23 6 3268962-3457022 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014697 Approved Approved Nucleoplasm
Vesicles
Cytosol Expressed in all stomach: 28.2 SLC24A1 CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX ENSG00000074621 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 15 65611366-65660995 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039370 Supported Approved Microtubules Mixed fallopian tube: 8.7 SLC24A5 JSX, OCA6 ENSG00000188467 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 5 15 48120972-48142672 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 22 skin: 9.6;testis: 3.0 breast: 0.2 SLC26A5 DFNB61, PRES ENSG00000170615 Solute carrier family 26 (anion exchanger), member 5 7 103352730-103446177 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Mixed breast: 1.2 SLC26A6 DKFZp586E1422 ENSG00000225697 Solute carrier family 26 (anion exchanger), member 6 3 48625723-48635493 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048363 Approved Uncertain Cytosol Expressed in all rectum: 24.3 SLC28A1 CNT1 ENSG00000156222 Solute carrier family 28 (concentrative nucleoside transporter), member 1 15 84884654-84945796 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019551 Supported Group enriched 26 duodenum: 39.0;kidney: 49.1;liver: 35.4;small intestine: 54.7 placenta: 1.6 SLC34A1 NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2 ENSG00000131183 Solute carrier family 34 (type II sodium/phosphate cotransporter), member 1 5 177379235-177398848 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA051255 Approved Tissue enriched 164 kidney: 161.0 liver: 0.9 SLC34A2 NAPI-3B ENSG00000157765 Solute carrier family 34 (type II sodium/phosphate cotransporter), member 2 4 25655301-25678748 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037989 Supported Tissue enriched 10 lung: 1127.5 fallopian tube: 111.7 SLC34A3 FLJ38680, NPTIIc ENSG00000198569 Solute carrier family 34 (type II sodium/phosphate cotransporter), member 3 9 137230757-137236554 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023776 Supported Group enriched 14 kidney: 11.8;small intestine: 9.2 testis: 0.7 SLC35A5 FLJ20730 ENSG00000138459 Solute carrier family 35, member A5 3 112561709-112585577 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035519, HPA057964 Uncertain Approved Golgi apparatus Expressed in all thyroid gland: 43.7 SLC35B1 UGTREL1 ENSG00000121073 Solute carrier family 35, member B1 17 49700943-49709014 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048655, HPA057418 Approved Approved Nucleus
Endoplasmic reticulum
Vesicles Expressed in all thyroid gland: 52.0 SLC35F1 C6orf169, dJ230I3.1 ENSG00000196376 Solute carrier family 35, member F1 6 117907526-118317676 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA019576 Approved Approved Nucleoplasm
Microtubule organizing center
Cytosol Tissue enriched 12 cerebral cortex: 45.6 epididymis: 3.7 SLC35F2 FLJ13018 ENSG00000110660 Solute carrier family 35, member F2 11 107790991-107928293 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048185, HPA050695 Uncertain Approved Mitochondria Mixed prostate: 33.0 SLC35F3 FLJ37712 ENSG00000183780 Solute carrier family 35, member F3 1 233904933-234324516 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051327, HPA061582 Uncertain Approved Nucleoli
Golgi apparatus Tissue enhanced 0 cerebral cortex: 10.2 breast: 3.0 SLC35F4 C14orf36, FLJ37712 ENSG00000151812 Solute carrier family 35, member F4 14 57563922-57982194 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043853 Uncertain Approved Nucleoli fibrillar center Tissue enhanced 0 prostate: 1.9;seminal vesicle: 4.9;testis: 1.8 thyroid gland: 1.0 SLC35F6 ANT2BP, C2orf18, FLJ20555, TANGO9 ENSG00000213699 Solute carrier family 35, member F6 2 26764284-26781231 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA034655 Approved Approved Nucleoplasm
Vesicles
Cytosol Expressed in all thyroid gland: 26.2 SLC35G3 AMAC1, FLJ40154, TMEM21A ENSG00000164729 Solute carrier family 35, member G3 17 35192520-35194523 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 15 testis: 1.6 skeletal muscle: 0.1 SLC35G5 AMAC, AMAC1L2 ENSG00000177710 Solute carrier family 35, member G5 8 11330888-11332208 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 testis: 1.5 spleen: 0.4 SLC35G6 AMAC1L3, TMEM21B ENSG00000259224 Solute carrier family 35, member G6 17 7481332-7483496 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 19 testis: 3.7 skeletal muscle: 0.1 SLC36A4 FLJ38932, PAT4 ENSG00000180773 Solute carrier family 36 (proton/amino acid symporter), member 4 11 93144171-93197964 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017887 Approved Approved Golgi apparatus
Plasma membrane
Cytosol Mixed thyroid gland: 14.7 SLC37A4 G6PT1, G6PT2, G6PT3, GSD1b, GSD1c, GSD1d ENSG00000137700 Solute carrier family 37 (glucose-6-phosphate transporter), member 4 11 119024114-119030906 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA038939, HPA038940 Approved Approved Mitochondria Tissue enhanced 0 duodenum: 31.4;kidney: 36.1 epididymis: 20.7 SLC38A11 AVT2, FLJ39822 ENSG00000169507 Solute carrier family 38, member 11 2 164896186-164955525 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043432 Uncertain Tissue enhanced 0 epididymis: 47.1;gallbladder: 28.3 seminal vesicle: 23.3 SLC38A2 ATA2, KIAA1382, SAT2, SNAT2 ENSG00000134294 Solute carrier family 38, member 2 12 46358189-46372867 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035180 Approved Approved Vesicles Expressed in all skin: 239.3 SLC38A7 FLJ10815 ENSG00000103042 Solute carrier family 38, member 7 16 58665109-58685104 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041777 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Mixed testis: 34.8 SLC38A9 FLJ90709 ENSG00000177058 Solute carrier family 38, member 9 5 55625845-55773194 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043785 Uncertain Approved Nucleoplasm
Vesicles Expressed in all placenta: 79.8 SLC41A1 MgtE ENSG00000133065 Solute carrier family 41 (magnesium transporter), member 1 1 205789093-205813748 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014721, HPA015138 Uncertain Approved Mitochondria Tissue enhanced 0 heart muscle: 72.6 testis: 37.3 SLC44A3 CTL3, MGC45474 ENSG00000143036 Solute carrier family 44, member 3 1 94820342-94895246 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047433 Approved Mixed rectum: 39.1 SLC44A4 C6orf29, CTL4, FLJ14491, NG22, TPPT ENSG00000204385 Solute carrier family 44, member 4 6 31863192-31879046 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA046977, HPA054176 Approved Tissue enhanced 0 duodenum: 36.0 prostate: 30.1 SLC4A4 hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5 ENSG00000080493 Solute carrier family 4 (sodium bicarbonate cotransporter), member 4 4 71187286-71572087 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022493, HPA035628, HPA035629 Supported Tissue enhanced 0 kidney: 124.6 cerebral cortex: 57.5 SLC4A5 NBC4 ENSG00000188687 Solute carrier family 4 (sodium bicarbonate cotransporter), member 5 2 74216242-74343414 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA036621 Approved Group enriched 9 testis: 25.5;thyroid gland: 40.5 skin: 3.7 SLC5A11 KST1, SGLT6, SMIT2 ENSG00000158865 Solute carrier family 5 (sodium/inositol cotransporter), member 11 16 24845841-24911628 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA035331 Uncertain Approved Nucleus
Cytosol Group enriched 6 cerebral cortex: 10.5;duodenum: 6.8;kidney: 6.0;small intestine: 15.5 breast: 1.7 SLC5A12 MGC52019, SMCT2 ENSG00000148942 Solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12 11 26667019-26723427 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA060904 Supported Tissue enhanced 0 epididymis: 57.8;kidney: 172.6 small intestine: 34.0 SLC6A9 GLYT1 ENSG00000196517 Solute carrier family 6 (neurotransmitter transporter, glycine), member 9 1 43991500-44031467 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA013977 Uncertain Approved Nucleus
Golgi apparatus Tissue enhanced 0 skin: 49.8 adrenal gland: 31.0 SLC7A8 LAT2, LPI-PC1 ENSG00000092068 Solute carrier family 7 (amino acid transporter light chain, L system), member 8 14 23125295-23183674 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB046015, HPA051950, HPA060672 Supported Tissue enriched 8 parathyroid gland: 1066.4 kidney: 131.5 SLC8A1 NCX1 ENSG00000183023 Solute carrier family 8 (sodium/calcium exchanger), member 1 2 40097270-40611053 FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022694, HPA070007 Uncertain Supported Nucleoplasm
Plasma membrane Tissue enhanced 0 heart muscle: 79.5 seminal vesicle: 38.2 SLC8A2 KIAA1087, NCX2 ENSG00000118160 Solute carrier family 8 (sodium/calcium exchanger), member 2 19 47428017-47472168 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA050818, HPA054671 Supported Tissue enriched 11 cerebral cortex: 68.4 endometrium: 6.2 SLC8B1 FLJ22233, NCKX6, NCLX, SLC24A6 ENSG00000089060 Solute carrier family 8 (sodium/lithium/calcium exchanger), member B1 12 113298759-113359493 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA040668 Approved Expressed in all adrenal gland: 48.6 SLC9B2 FLJ23984, NHA2, NHEDC2 ENSG00000164038 Solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2 4 103019868-103085829 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047008 Uncertain Approved Nucleoplasm
Cell Junctions Tissue enhanced 0 cerebral cortex: 32.6 liver: 20.5 SLCO2B1 OATP-B, OATP2B1, SLC21A9 ENSG00000137491 Solute carrier organic anion transporter family, member 2B1 11 75100563-75206549 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA020659 Uncertain Expressed in all liver: 123.0 SOAT1 ACAT, SOAT, STAT ENSG00000057252 Sterol O-acyltransferase 1 1 179293714-179358680 Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009533, HPA047171 Supported Validated Endoplasmic reticulum Tissue enhanced 0 adrenal gland: 219.3 prostate: 44.0 SPNS1 HSpin1, LAT, nrs, PP2030, SPIN1, SPINL ENSG00000169682 Spinster homolog 1 (Drosophila) 16 28974221-28984548 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041995, HPA042988 Supported Approved Nucleoli fibrillar center
Golgi apparatus
Vesicles
Cytosol Expressed in all parathyroid gland: 36.3 SPPL2A IMP3, PSL2 ENSG00000138600 Signal peptide peptidase like 2A 15 50702266-50765808 Enzymes, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036062, HPA067304 Supported Supported Vesicles Expressed in all parathyroid gland: 285.5 SPPL2B IMP4, KIAA1532, PSL1 ENSG00000005206 Signal peptide peptidase like 2B 19 2328615-2354806 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039292 Approved Nucleoplasm
Plasma membrane
Centrosome Expressed in all testis: 49.2 SPPL2C IMP5 ENSG00000185294 Signal peptide peptidase like 2C 17 45844835-45847072 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 21 testis: 2.1 adipose tissue: 0.0 SPPL3 DKFZP586C1324, IMP2, MGC126674, MGC126676, MGC90402, PSL4 ENSG00000157837 Signal peptide peptidase like 3 12 120762510-120904371 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA004194, HPA059958 Uncertain Supported Vesicles
Plasma membrane Expressed in all parathyroid gland: 82.3 STRA6 FLJ12541 ENSG00000137868 Stimulated by retinoic acid 6 15 74179466-74212267 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040839 Approved Approved Nucleus
Cytosol Tissue enhanced 0 cervix, uterine: 37.3;placenta: 20.4 endometrium: 13.5 TAP1 ABCB2, D6S114E, PSF1, RING4 ENSG00000168394 Transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) 6 32845209-32853978 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009516, HPA072354 Approved Supported Endoplasmic reticulum
Microtubule organizing center Mixed appendix: 20.6 TM9SF1 HMP70, MP70 ENSG00000100926 Transmembrane 9 superfamily member 1 14 24189143-24195687 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA059249 Supported Approved Golgi apparatus Expressed in all parathyroid gland: 71.2 TM9SF2 P76 ENSG00000125304 Transmembrane 9 superfamily member 2 13 99501417-99564006 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005657 Supported Expressed in all thyroid gland: 201.3 TM9SF3 SMBP ENSG00000077147 Transmembrane 9 superfamily member 3 10 96518109-96587452 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039609 Approved Approved Golgi apparatus
Vesicles Expressed in all stomach: 182.0 TM9SF4 dJ836N17.2, KIAA0255 ENSG00000101337 Transmembrane 9 superfamily protein member 4 20 32109506-32167258 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA064099 Approved Approved Mitochondria Expressed in all parathyroid gland: 91.3 TMC1 DFNA36, DFNB11, DFNB7 ENSG00000165091 Transmembrane channel-like 1 9 72521801-72836351 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cervix, uterine: 1.6 testis: 1.0 TMC2 C20orf145, dJ686C3.3 ENSG00000149488 Transmembrane channel-like 2 20 2536607-2641784 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA046350 Uncertain Tissue enhanced 0 testis: 1.0 lung: 0.8 TMC3 ENSG00000188869 Transmembrane channel-like 3 15 81331217-81374213 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA040265, HPA040510 Approved Supported Cytosol Tissue enriched 79 parathyroid gland: 248.1 epididymis: 3.1 TMC4 ENSG00000167608 Transmembrane channel-like 4 19 54160108-54173250 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA048635 Approved Tissue enhanced 0 duodenum: 31.3 small intestine: 22.6 TMC5 FLJ13593 ENSG00000103534 Transmembrane channel-like 5 16 19410496-19499113 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA040810, HPA042037 Approved Approved Nucleus
Plasma membrane Tissue enhanced 0 small intestine: 60.2 duodenum: 46.6 TMC6 EVER1, EVIN1, LAK-4P ENSG00000141524 Transmembrane channel-like 6 17 78110458-78132407 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051430 Uncertain Expressed in all spleen: 84.5 TMC8 EVER2, EVIN2 ENSG00000167895 Transmembrane channel-like 8 17 78130770-78142968 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047387, HPA054429 Uncertain Uncertain Golgi apparatus Tissue enhanced 0 lymph node: 120.4;spleen: 107.5 appendix: 75.5 TMEM144 FLJ11155 ENSG00000164124 Transmembrane protein 144 4 158201604-158255411 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043767, HPA063554 Uncertain Approved Mitochondria Tissue enhanced 0 cerebral cortex: 90.8 testis: 46.6 TMEM180 bA18I14.8, C10orf77, FLJ22529 ENSG00000138111 Transmembrane protein 180 10 102461395-102477045 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA018031 Uncertain Approved Golgi apparatus
Cytosol Mixed skin: 8.8 TMEM241 C18orf45, FLJ44259, MGC11386 ENSG00000134490 Transmembrane protein 241 18 23197144-23437961 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA029489, HPA059922 Uncertain Approved Golgi apparatus
Vesicles Mixed cerebral cortex: 4.3 TMEM260 C14orf101, FLJ20392 ENSG00000070269 Transmembrane protein 260 14 56488354-56650606 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA003502 Uncertain Approved Nucleus
Focal adhesion sites
Cytosol Tissue enhanced 0 cervix, uterine: 63.2 thyroid gland: 14.0 TMEM63B C6orf110, dJ421H19.2, DKFZp434P0531 ENSG00000137216 Transmembrane protein 63B 6 44126914-44155519 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029249, HPA029250, HPA029251 Uncertain Validated Plasma membrane
Actin filaments Expressed in all lung: 59.2 TMTC1 ARG99, FLJ31400, FLJ41625, OLF ENSG00000133687 Transmembrane and tetratricopeptide repeat containing 1 12 29500840-29784759 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA016720 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 spleen: 61.6 adipose tissue: 41.5 XKR4 KIAA1889 ENSG00000206579 XK, Kell blood group complex subunit-related family, member 4 8 55102389-55542054 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA025072, HPA028083 Uncertain Tissue enriched 6 cerebral cortex: 4.7 seminal vesicle: 0.8 XPR1 SYG1, X3 ENSG00000143324 Xenotropic and polytropic retrovirus receptor 1 1 180632004-180890251 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016557 Supported Approved Endoplasmic reticulum
Golgi apparatus Expressed in all testis: 31.1